Table 2

Pharmacokinetic parameters of lactone and carboxylate forms of SN-38 after i.v. administration of CPT-11 (10 and 40 mg/kg) in SD rats and EHBR

Lactone FormCarboxylate Form
10 mg/kg40 mg/kg10 mg/kg40 mg/kg
SD rats
 AUC(0–8hr) (μg · hr/ml)0.100  ± 0.0090.209  ± 0.0320.0474  ± 0.00810.249  ± 0.064
X liver(8hr) (μg/g liver)0.0293  ± 0.00560.239  ± 0.0770.0487  ± 0.00730.207  ± 0.045
X bike(0-8hr) (mg/kg)0.0140  ± 0.00110.0196  ± 0.00350.207  ± 0.0530.191  ± 0.049
CL bile,p (ml/min/kg)2.43  ± 0.381.53  ± 0.0572.0  ± 10.115.5  ± 5.3**
CL bile,h (ml/min/kg)0.440  ± 0.1730.123  ± 0.0345.46  ± 0.921.92  ± 0.97*
C bile/C liver 10.1  ± 6.04.05  ± 0.66118  ± 2652.6  ± 12.5*
X urine(0–8hr) (mg/kg)0.0738  ± 0.00630.142  ± 0.0350.0338  ± 0.00830.0229  ± 0.0053
CL r (liter/kg · hr)0.754  ± 0.0920.740  ± 0.1050.784  ± 0.2130.109  ± 0.032*
EHBR
 AUC(0–8hr) (μg · hr/ml)0.117  ± 0.0050.152  ± 0.0120.339  ± 0.0780.245  ± 0.060
X liver(8hr) (μg/g liver)0.0700  ± 0.00200.0558  ± 0.00240.268  ± 0.0120.171  ± 0.019
X bile(0–8hr) (mg/kg)0.0110  ± 0.00250.0192  ± 0.00310.104  ± 0.0260.256  ± 0.062
CL bile,p (ml/min/kg)1.61  ± 0.382.09  ± 0.227.1  ± 1.5 24.5  ± 10.9
CL bile,h (ml/min/kg)0.183  ± 0.0380.453  ± 0.136* 0.553  ± 0.121 2.57  ± 0.91*
C bile/C liver 4.10  ± 2.0513.3  ± 1.7** 11.6  ± 6.2 68.9  ± 10.3*
X urine(0–8hr) (mg/kg)0.0485  ± 0.01970.0715  ± 0.01590.0799  ± 0.01520.0543  ± 0.0175
CL r (liter/kg · hr)0.398  ± 0.1580.496  ± 0.1280.242  ± 0.010 0.224  ± 0.075

All values are given as the mean ± S.E. of three different experiments.

  • * P < .05, ** P < .01, significantly different from 10 mg/kg dose, using Dunnett’s test.

  • † P < .05, ‡ P < .01, significantly different from SD rats, using Dunnett’s test.